Long-Acting Muscarinic Antagonists Aid Asthma Care in Kids
Long-acting muscarinic antagonists (LAMAs), as add-on therapy to inhaled corticosteroids, improved peak forced expiratory volume in 1 second (FEV1) and reduced exacerbations in children younger than 12 years with moderate-to-severe asthma.
METHODOLOGY:
Researchers conducted a meta-analysis to assess the efficacy and safety of LAMAs as add-on therapy to inhaled corticosteroids in children with moderate-to-severe asthma.
They included four randomized controlled trials and two observational studies, comprising 1210 children (0.5-11 years), that evaluated tiotropium as LAMA of choice, with a median follow-up of 15 weeks.
All participants received inhaled corticosteroids both before and after screening and randomization, with mean doses ranging from 228 μg to 480 μg of budesonide or an equivalent dose.
The primary outcome was a change in FEV1. Other outcomes evaluated were peak FEV1, forced vital capacity (FVC), forced expiratory flow 25%-75% (FEF25%-75%), and asthma control assessed via interviewer-administered asthma control questionnaire (ACQ-IA) scores.
TAKEAWAY:
LAMAs at any dose significantly improved peak FEV1 (mean difference [MD], 86.16 mL; P < .01), with 5 μg tiotropium leading to a greater improvement (MD, 113.05 mL; P < .01).
< .01), with 5 μg tiotropium leading to a greater improvement (MD, 113.05 mL; < .01). FEF25%-75% demonstrated significant improvements with LAMAs (MD, 0.2518 L; 95% CI, 0.1971-0.3064; P < .01), while peak FVC showed no significant change.
< .01), while peak FVC showed no significant change. Treatment with LAMAs was associated with improved asthma control, as assessed by ACQ-IA scores (MD, -0.07; P < .01), and a reduced risk for exacerbations (risk ratio [RR], 0.75; P = .013).
< .01), and a reduced risk for exacerbations (risk ratio [RR], 0.75; = .013). Treatment with LAMAs was associated with fewer adverse events than control (RR, 0.88; P = .021). No deaths were reported, and no adverse events led to treatment discontinuation in any of the included studies.
IN PRACTICE:
'We found that LAMA as an add-on therapy to ICS [inhaled corticosteroids], with or without associated LABA [long-acting beta-agonists], is effective and safe for moderate and severe asthma in children aged 6-11, improving lung function parameters in spirometry and protecting against exacerbations,' the authors wrote.
SOURCE:
This study was led by Gabriel Bolner, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. It was published online on May 5, 2025, in Paediatric Respiratory Reviews .
LIMITATIONS:
This study included only patients with moderate-to-severe asthma or persistent symptoms, limiting the understanding of potential benefits for children with better-controlled asthma. Additionally, only one study included children aged 5 years or younger, making this population underrepresented in the pooled analysis.
DISCLOSURES:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. No conflicts of interest were mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
an hour ago
- Fox News
GOP lawmaker grills ex-CEO over 23andMe pronouns post, forcing her to admit she doesn't know what they mean
Rep. Brandon Gill, R-Texas, grilled 23andMe co-founder and former CEO Anne Wojcicki on Tuesday about a social media post regarding transgender pronouns, forcing her to admit she is not "up to speed" about what they mean. Lawmakers are in the process of launching an investigation to assess the risk of 23andMe users' genetic data being transferred to third party buyers amid the company's bankruptcy. Wojcicki testified before a U.S. House committee a few months after she stepped down as CEO of the genetics analysis company in March. While the hearing was focused on data privacy as the company potentially changes hands, Gill questioned the former CEO about a politically-charged post the company's official X account made under her watch. "23andMe has really, over the past few years, gone out of its way to show how woke it is. And one of the things that it's been promoting, among many others, is a variety of different pronouns," he said as he shared a Pride month post from 2021. "Science shows using correct pronouns can impact trans people's health by significantly reducing their risk of depression and suicide. This is one of many reasons why we have been working to improve our product for trans and non-binary customers," the post said, along with a graphic showing 14 pronouns ranging from the standard "He, him, she, her," to the esoteric "ze, hir, xe, xem, fae, faer, e, em." The tweet linked to a 23andMe company blog post headlined, "Trust the Science by Supporting Trans Health Care." The piece said "medical experts" support allowing trans people to use the bathroom of their gender identity, and defended "Gender-affirming health care" for children by citing pediatric guidelines. Gill pressed the former CEO about the X post, noting one of the pronouns in particular, "I just wanna ask you, what does 'e' mean as a pronoun?" "To be honest, I am not sure," Wojcicki replied. "Okay, do you know what 'em' means as a pronoun?" Gill asked. "I'm also not sure," the former CEO replied. "Don't you think it's important to know what these mean? You guys are – In this post you wrote, or somebody in your comms team wrote, that using the correct pronouns impacts trans people's health and reduce the risk of depression and suicide," Gill said. "That's a pretty serious claim. It seems like if you're gonna demand people use these pronouns you would know what they mean, right?" "I was CEO, but that doesn't mean I can oversee every single post," Wojcicki said. "Very very politically charged post that you guys put out, I would think that you'd have a view on that," Gill said, going on to ask the former CEO the difference between the 'xe' and 'ze' pronouns. "I'm not up to speed on that," she replied. Grill pressed Wojcicki again on whether she felt like not understanding these pronouns indeed marginalizes transgender people, and she replied that she supports her research team who felt that it is important for the company "to be inclusive of everybody." Gill went on to argue that even if the social and research team had put out the messaging, she was CEO at the time, and cannot "pawn off responsibility to somebody else." Referring to the company blog post, he asked whether it had been 23andMe's policy to allow biological men to use the women's restroom while she was still the CEO. After noting the company had non-gendered bathrooms as well, Wojcicki answered that while she was CEO, "I think our position was just to make sure that we're applicable to laws." He then grilled her about the post mentioning support for transgender procedures for youth, and Wojcicki defended it by noting that it cited specific pediatric guidelines. "Sounds to me like you took a genetics company that you built - and congratulations for doing that - and turned it into a woke social justice organization," Gill said, claiming that she is now running from such a position now that such ideas have fallen from popularity.
News24
an hour ago
- News24
Why your kidneys are your body's silent heroes and how to keep them healthy
Kidneys are the silent heroes of your body. Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once. Start your FREE trial now
CNN
2 hours ago
- CNN
US foreign aid cuts threaten decades of progress on driving down malaria
Cuts to US-funded malaria programs are adding to a host of issues confronting Congolese mother Mwayuma Idi Feza, whose city, Goma, is at the center of the country's intensifying conflict and run by a vicious militia. 'I have a child who is sick. He has had malaria for a week and a few days now,' Feza, 36, told CNN of her 1-year-old son, whose fever she suspects is caused by the mosquito-borne illness. She is also experiencing symptoms of the disease, she said. 'I'm feeling cold. I feel bitterness in my mouth.' The single mother is out of work and said she can barely afford food, much less malaria treatment for her and her baby. Malaria is a preventable and curable disease, but it still claims hundreds of thousands of lives around the world each year. Infants, children under five and pregnant women are most likely to die from a malaria infection. It's a leading cause of death in the Democratic Republic of Congo (DRC), which bears the world's second-highest malaria burden after Nigeria, according to the World Health Organization (WHO). In 2022, some 24,000 people were estimated to have died of the disease in the central African nation. More than half those deaths were of children under 5. Since the Trump administration started slashing foreign aid early this year, an estimated 36% of US Agency for International Development (USAID) funding for malaria programs has been cut, according to the Center for Global Development, a DC-based think tank. But the true level of aid cuts remains uncertain. In the DRC, that money funded the supply of antimalarials to 'many health zones' across the country, 'including intermittent preventive treatment for pregnant women,' according to Michel Itabu, a former spokesperson for the country's National Malaria Control Program (PNLP), referring to a WHO-recommended program in areas where malaria is endemic. 'The PNLP is already feeling the effects' of the funding cuts, Itabu told CNN. Such preventive programs might have protected Idi Feza and her baby son – instead, if infected, they are both at risk of serious illness or even death. The US government has long been the largest donor to global efforts to combat malaria. For decades, USAID spearheaded a program called the President's Malaria Initiative (PMI) to drive down mortality and eliminate malaria in 30 of the hardest-hit nations, most of which are in Africa. Launched by George W. Bush in 2005, the program helped reduce malaria deaths by more than 60% – saving millions of lives. CNN spoke to several people who previously worked on the initiative but were recently laid off amid Trump's dismantling of USAID. Most PMI staff have been let go or had their work halted by stop-work orders, and the Trump administration's proposed budget called for a 47% cut to the program. 'One of the reasons that we don't have malaria in the US is because we fund and track malaria worldwide, for global health security.' Former USAID contractor, speaking anonymously for fear of reprisals Every aid worker who spoke to CNN emphasized that people would die in the short term as a result of the disruption to malaria prevention and treatment efforts. Longer term, they said the funding cuts would destroy years of American progress in driving down the prevalence and severity of the disease. US-backed surveillance systems that were once the backbone of efforts to monitor malaria and other disease outbreaks around the world have also been cut, former US government workers told CNN, underscoring long-term concerns. 'One of the reasons that we don't have malaria in the US is because we fund and track malaria worldwide, for global health security,' one former USAID contractor told CNN in February, speaking anonymously for fear of reprisals. She warned that locally acquired malaria cases, like Florida experienced in 2023, could become more common 'if we're not funding driving down the parasite elsewhere.' Aid workers and nonprofits have repeatedly made the case that malaria programs and US disease monitoring make America 'safer, stronger and more prosperous,' which was Secretary of State Marco Rubio's stated framework for assessing US foreign assistance. For example, USAID and the US military have long invested in malaria vaccine research to both reduce the global disease burden and protect US soldiers serving abroad. Spencer Knoll, US policy and advocacy director at the nonprofit Malaria No More, said in testimony to the US House Appropriations Subcommittee in April that 'the world's most dangerous infectious diseases – including Ebola, Marburg, and pandemic influenza – often present first as fevers, and malaria detection programs can stop outbreaks in their tracks.' The nonprofit also argued that US assistance prevents other countries like China and Iran from making further inroads in Africa in terms of soft power. 'Everything that comes from USAID… was very intentionally branded, with this logo that says 'from the American people.' People know where it was coming from,' said former PMI contractor Annē Linn, who lost her job in January. 'When all of a sudden everything stops, that just tears down trust – not just from our government to other governments, but within countries' own health systems.' Between 2010 and 2023, the US contributed more than one-third of the world's malaria financing, according to WHO. As of last year, the US was also the largest contributor to the Global Fund, which works to fight AIDS, tuberculosis and malaria. It's unclear what the future level of US funding for the independent, public-private program will be, following the Trump administration's proposal to halve US matching contributions. The Trump administration's funding cuts 'could reverse decades of progress earned, in part, through longstanding investments from the United States of America and other global partners,' WHO warned in a statement earlier this year. 'Although funding for some USA-supported malaria programs have been reinstated, the disruptions have left critical gaps.' The US State Department did not respond to questions from CNN about the stop-work orders and where specifically budget cuts to the PMI would be felt. Former aid workers emphasized concerns about lack of investment to tackle several global threats related to malaria, including drug resistance, increasingly insecticide-resistant mosquitoes and new, invasive types of mosquitoes that are moving into urban areas with high populations. 'The timing for all of this couldn't be worse. Malaria is seasonal, and so having interruptions during times of seasonality sets us back significantly,' said Nathaniel Moller, formerly a senior innovation adviser at the PMI, whose job was cut in January. He warned that with less funding for measures like bed nets and preventative medicine, the baseline of cases will rise this year, enabling further spread of the disease down the road. 'You missed that window, and you can't just go back to that initial baseline… it's going to go up,' Moller said, noting that the rainy season is already underway in parts of east, central and southern Africa. 'We risk losing years of investments and seeing the caseload increase significantly.' That bad timing is particularly evident in Malawi, where recent flooding and cyclones have driven up malaria infections, the country's National Malaria Control Manager Lumbani Munthali told CNN. He added that cuts to USAID funding for malaria interventions have put the country in 'a difficult situation' because 'it's not easy to close the gaps that have been created.' More than 2,000 people died of malaria in Malawi last year. Some 9 million were infected. 'Malawi has made significant progress in reducing malaria deaths because of the technical and financial support from the US government,' Munthali said. That funding went towards procuring millions of malaria tests kits annually and providing insecticide-treated bed nets and antimalarial medication for pregnant women and nursing mothers. 'We are trying to close those gaps but may not close them completely,' Munthali said, as Malawi adjusts to the sharp drop-off in US foreign aid. About 64% of Malawi's USAID funding has been cut across all programs, according to the Center for Global Development's analysis. In 2023, the most recent year for which PMI figures are available, Malawi received $24 million for its fight against malaria. It's not yet clear exactly how much it will lose this year, Munthali said. Cuts to other areas of US foreign aid, like malnutrition programs, will have overlapping effects in Africa, aid workers also warned. 'Kids that are acutely malnourished will be more vulnerable to other diseases,' like measles, cholera and malaria, according to Nicolas Mouly, an emergency coordinator for Doctors Without Borders, or Médecins Sans Frontières (MSF), who works in northwest Nigeria. He said funding gaps for malnutrition programs that were already present in 2024 have deepened significantly this year. Malaria infection can also lead to malnutrition, fueling what MSF has called 'a vicious cycle.' Nigeria's health minister, Muhammad Ali Pate, told CNN that the government has mobilized domestic funding for its health sector, including $200 million recently approved by parliament to lessen the effects of losing USAID funding. 'When the change in US government occurred and the policy was made, we considered it as another opportunity for reset and for us to increase our domestic funding so that we can meet the responsibility of the health of our population,' he said. 'At the end of the day, the responsibility of the health of Nigerians is on the Nigerian government. It is never a primary responsibility of the US government.' MSF doesn't rely on US government funding, but the organization said its programs have been burdened with additional patients following US cuts to other humanitarian actors in the region. 'We won't have the capacity to treat all of them,' Mouly said. Aid organizations prepare for the annual peak of malnutrition – when fall harvests have yet to arrive and rainy seasons have increased malaria cases – by stockpiling ready-to-use therapeutic food sachets. But for this year's lean season, Mouly said there is 'uncertainty' about their availability. 'We can expect a very critical situation,' Mouly said, emphasizing that children will die as a result. 'We've not seen anything like this in terms of disruption of global aid. It's very difficult.' Lauren Kent reported and wrote from London. Nimi Princewill reported from Abuja, Nigeria.
